This is a condition affecting the clear front part of your eye, called the cornea. It happens when the thin layer of cells at the back of the cornea, called the endothelium, starts to break down. This can make your vision blurry or cloudy, and sometimes cause pain. It's a slow disease that usually develops over many years.
Every report comes from a Lived member, sent anonymously.
Have you had Corneal Transplant for Fuchs' Endothelial Dystrophy?
Fuchs' endothelial dystrophy is a genetic disease of the cornea, the clear dome at the front of the eye. The innermost layer of the cornea, called the endothelium, is a single sheet of cells that constantly pumps fluid out of the cornea to keep it clear. In Fuchs' dystrophy these cells gradually die. As they are lost, fluid builds up, the cornea swells and vision becomes cloudy or hazy. The first sign is often blurry vision when you wake up that clears as the day goes on. Overnight, with the eyes closed, the cornea holds more fluid; once the eyes are open, some of it evaporates. As the disease advances, the swelling no longer clears and vision stays blurry all day. People may also notice glare, halos around lights, sensitivity to bright light, and vision that is worse in humid weather. In later stages, tiny blisters can form on the surface of the cornea and burst, causing pain and a gritty feeling. The condition affects both eyes, though one is often worse than the other. It progresses slowly, usually over decades.
Fuchs' dystrophy is a genetic condition, but its genetics are only partly understood. It often runs in families, and having a parent or sibling with it raises your risk. Variants in several genes have been linked to the common form, which usually starts to affect vision in a person's forties or fifties or later. A very rare early-onset form, which can affect vision in the twenties, is sometimes caused by changes in a gene called COL8A2 and can be passed from one parent to a child. Many people with Fuchs' dystrophy have no known family history. Women develop it two to four times more often than men, for reasons that are not clear. It is fairly common: in the United States, roughly 4 percent of people over 40 have it, though many have mild changes that never seriously affect their sight.
Fuchs' dystrophy is diagnosed during an eye exam, often by an ophthalmologist who specializes in the cornea. Using a slit lamp (a microscope with a bright light), the doctor looks for guttae: tiny drop-like bumps on the back surface of the cornea that are the hallmark of the disease. Guttae can be present years before vision changes, so the condition is sometimes found during a routine exam or a check before cataract surgery. Two measurements help show how far the disease has progressed. Pachymetry measures how thick the cornea is; a thicker cornea than expected means it is holding extra fluid. Specular microscopy photographs the endothelium so the cells can be counted. A healthy young cornea has about 4,000 endothelial cells per square millimeter, and the number falls slowly with age. When it drops to around 500, the remaining cells can no longer keep the cornea clear. Scans of the cornea's shape can also reveal early swelling that is not yet visible on exam, which helps predict whether the cornea is likely to cope with cataract surgery. Because blurry vision and glare are also common with cataracts, part of the assessment is working out how much of a person's vision loss comes from the cornea and how much from the lens.
There is no medicine that stops Fuchs' dystrophy from progressing, and many people with early disease simply need regular monitoring. When symptoms start, treatment aims to reduce corneal swelling, and when vision is significantly affected, surgery can replace the failing cells. In earlier stages, salt-based (hypertonic saline) eye drops or ointment can draw some fluid out of the cornea and may ease morning blur for a while, although a randomized trial found less benefit than expected. Some people use a hair dryer held at arm's length to blow warm air across the face in the morning, which helps the surface of the cornea dry out. These measures can make daily life easier but do not change the course of the disease. The main treatment for vision loss is a partial corneal transplant called endothelial keratoplasty. Instead of replacing the whole cornea, the surgeon removes the diseased inner layer and replaces it with healthy cells from a donor cornea, held in place by a small air bubble. The most refined version, Descemet membrane endothelial keratoplasty (DMEK), transplants only the thin back membrane and its cells; it generally gives the fastest visual recovery and the lowest risk of the graft failing. A slightly thicker graft (DSAEK) is also widely used. Both have largely replaced full-thickness corneal transplants for Fuchs', which involve stitches and a much longer recovery. After any transplant, steroid eye drops are used for a long time, often years, to lower the risk of the body rejecting the donor tissue. For some people with disease concentrated in the center of the cornea, surgeons may offer Descemet stripping only, which removes the central diseased cells without a donor graft and lets healthy cells from the edge of the cornea spread inward. Clearing takes longer than with a transplant, and some eyes still need a transplant afterward. Rho kinase inhibitor drops such as netarsudil (Rhopressa), approved in the United States to treat glaucoma, are being studied for Fuchs' dystrophy, sometimes alongside this procedure, but are not approved for it. Cataract surgery deserves special planning. It can stress an already weakened endothelium and tip a borderline cornea into lasting swelling. Depending on how healthy the cornea is, surgeons may recommend cataract surgery alone, cataract surgery combined with a transplant, or the two done in stages.
Fuchs' dystrophy usually changes slowly over many years, and its pace varies. Some people have guttae for decades with little effect on their vision. Others gradually move from morning blur to haze that lasts all day, which can make reading, driving at night and screen work harder. Regular eye exams track corneal thickness and vision so treatment can be timed to when symptoms begin to interfere with daily life. Endothelial transplant has changed the outlook considerably. Many people regain clear, useful vision, often in both eyes over time. Recovery involves several follow-up visits in the first weeks and a long course of eye drops. Vision can keep improving for months. A transplant replaces the diseased cells, but the new tissue needs lifelong attention, and some grafts eventually need to be repeated.
See an eye doctor if your vision is blurry or hazy when you wake up, if glare or halos are making night driving difficult, or if you have a family history of Fuchs' dystrophy and are noticing vision changes. If you already have the diagnosis, mention it before any eye surgery, especially cataract surgery. Contact your eye doctor promptly if you develop eye pain or a gritty feeling that does not settle, since a burst corneal blister can be painful and can let infection in. If you have had a corneal transplant, call your eye doctor's office right away for new redness, light sensitivity beyond what is usual for you, cloudy or foggy vision, or pain or irritation without an obvious cause. These can be signs of rejection, which can often be reversed when it is treated early. Do not stop your prescribed steroid drops unless your surgeon tells you to.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Fuchs' Endothelial Dystrophy is like, what's helped you, or ask the community a question.